| 吉西他滨联合顺铂治疗晚期非小细胞肺癌的临床研究 |
| |
| 引用本文： | 毕庆军,韩蕊.吉西他滨联合顺铂治疗晚期非小细胞肺癌的临床研究[J].中国煤炭工业医学杂志,2006,9(11):1133-1134. |
| |
| 作者姓名： | 毕庆军 韩蕊 |
| |
| 作者单位： | 255067,山东省淄博市第四人民医院 |
| |
| 摘 要： | 目的 观察吉西他滨加顺铂联合化疗治疗非小细胞肺癌的近期疗效及毒副作用。方法 50例Ⅲb～Ⅳ期非小细胞肺癌，采用吉西他滨1000mg／m^2，静滴，d1、d8；顺铂30mg／m^2，静滴，d2～d4．联合化疗。结果 50例中CR＋PR 23例，有效率46％，主要毒副作用为骨髓抑制。结论 吉西他滨加顺铂联合化疗治疗晚期非小细胞肺癌疗效较好．毒副作用可耐受，值得临床推广应用。
|
| 关 键 词： | 吉西他滨 顺铂 非小细胞肺癌 联合化疗 |
| 文章编号： | 1007-9564（2006）11-1133-02 |
| 收稿时间： | 2006-05-25 |
| 修稿时间： | 2006-08-04 |
GEMCITABINE COMBINED CISPLATIN REGIMEN IN TREATMENT OF ADVANCED LUNG CANCER |
| |
| Bi Qingjun,Han Rui.GEMCITABINE COMBINED CISPLATIN REGIMEN IN TREATMENT OF ADVANCED LUNG CANCER[J].Chinese Journal of Coal Industry Medicine,2006,9(11):1133-1134. |
| |
| Authors: | Bi Qingjun Han Rui |
| |
| Abstract: | Objective To observe the near future effect of gemcitabine combined cisplatin regimen in the treatment of patients with advanced lung cancer.Methods 50 patients with advanced lung cancer were treated with GP regimen: GEM 1000mg/m,iv,d1~d8;DDP 30mg/m,iv,d2~d4.Results It showed that CR+PR 23,and overall response rate was 46%.The main effect was leukocytopenia.Conclusion Gemcitabine and cisplatin regimen show more better effect on advanced non-small cell lung cancer,furthermore its toxic reaction is tolerable. |
| |
| Keywords: | gemcitabine cisplatin advanced lung cancer combined chemotherapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
